成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 144701-48-4 Chemical Structure| 144701-48-4

Structure of Telmisartan
CAS No.: 144701-48-4

Chemical Structure| 144701-48-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 144701-48-4

,{[proInfo.pro_purity]}

Telmisartan is a potent and long-lasting antagonist of the angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with an IC50 of 9.2 nM.

Synonyms: BIBR 277; Micardis; Kinzalmono

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Telmisartan

CAS No. :144701-48-4
Formula : C33H30N4O2
M.W : 514.62
SMILES Code : O=C(C1=CC=CC=C1C2=CC=C(CN3C4=CC(C5=NC6=CC=CC=C6N5C)=CC(C)=C4N=C3CCC)C=C2)O
Synonyms :
BIBR 277; Micardis; Kinzalmono
MDL No. :MFCD00918125
InChI Key :RMMXLENWKUUMAY-UHFFFAOYSA-N
Pubchem ID :65999

Safety of Telmisartan

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Related Pathways of Telmisartan

GPCR

Isoform Comparison

Biological Activity

Target

  • AT2 receptor

In Vitro:

Cell Line
Concentration Treated Time Description References
BV2 cells 10 μM 3 hours Telmisartan showed neuroprotective effects in BV2 cells, reducing LPS-induced inflammatory gene expression and enhancing anti-inflammatory gene expression. PMC6677563
KYSE150 cells 10, 50, 100 μM 48 hours Telmisartan dose-dependently inhibited the proliferation of KYSE150 cells and induced S-phase arrest. PMC6651359
KYSE180 cells 10, 50, 100 μM 48 hours Telmisartan dose-dependently inhibited the proliferation of KYSE180 cells and induced S-phase arrest. PMC6651359
KYSE850 cells 10, 50, 100 μM 48 hours Telmisartan dose-dependently inhibited the proliferation of KYSE850 cells and induced S-phase arrest. PMC6651359
H9c2 cells 50 μM 60 minutes To investigate the protective effects of Telmisartan on hypoxia/reoxygenation-induced damage in cardiomyocytes, results showed that Telmisartan significantly reduced the increment of miR-1 and increased the expressions of Cnx43, KCNQ1, and Bcl-2. PMC6787508

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Experimental glaucoma model Oral 2 g/kg Once daily for 12 weeks Telmisartan significantly reduced axon degeneration in mice with experimental glaucoma, suggesting a neuroprotective effect. PMC7405778
C57BL/6N High-fat diet-induced obesity model Oral gavage 8 mg/kg bw Daily for 8, 16, or 24 weeks Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior. Telmisartan treatment restored high-fat diet-induced neurovascular coupling impairment and improved cerebral blood flow. Additionally, telmisartan reduced high-fat diet-induced anxiety-like behavior. PMC8393307
Nude mice KYSE180 cell xenograft model Intraperitoneal injection 10 μg/day, 50 μg/day Once daily for three weeks Telmisartan inhibited tumor growth in the KYSE180 cell xenograft model, with significant reduction in tumor volume in the high-dose group. PMC6651359
Sprague-Dawley rats Myocardial ischemia/reperfusion injury model Gastric gavage 12 mg/kg/d Once daily for 3 weeks To investigate the protective effects of Telmisartan on myocardial ischemia/reperfusion injury, results showed that Telmisartan significantly reduced infarct size and increased the expressions of Cnx43, KCNQ1, and Bcl-2, while down-regulating miR-1. PMC6787508

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01392534 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT02177500 Hypertension Phase 3 Completed - -
NCT02129192 Healthy Phase 1 Completed - Japan ... More >> Boehringer Ingelheim Investigational Site Tokyo, Hachioji, Japan Less <<
NCT01426100 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Kandong Sacred Heart Hospital Anyang, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of DonGuk University Ilsan Hospital Goyang, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Goyang, Korea, Republic of Gachon University Gil Medical Center Inchon, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Bundang Cha Medical Center Seoul, Korea, Republic of Ewha Womans University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Inje University Ilsan Paik Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul, Korea, Republic of St. Paul's Hospital, The catholic University of Korea Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT02129192 - Completed - -
NCT02176499 Hypertension Phase 3 Completed - -
NCT01842256 Essential Hypertension ... More >> Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01911780 Hypertension Phase 3 Completed - Japan ... More >> 1348.2.020 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan 1348.2.008 Boehringer Ingelheim Investigational Site Chuo-ku, Fukuoka, Fukuoka, Japan 1348.2.018 Boehringer Ingelheim Investigational Site Chuo-ku,Kobe, Hyogo, Japan 1348.2.006 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1348.2.013 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1348.2.021 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1348.2.012 Boehringer Ingelheim Investigational Site Hirakata, Osaka, Japan 1348.2.011 Boehringer Ingelheim Investigational Site Kasaoka, Okayama, Japan 1348.2.001 Boehringer Ingelheim Investigational Site Kawasaki, Kanagawa, Japan 1348.2.019 Boehringer Ingelheim Investigational Site Kita-ku, Osaka-shi, Osaka, Japan 1348.2.014 Boehringer Ingelheim Investigational Site Kiyota-ku, Sapporo-shi, Hokkaido, Japan 1348.2.002 Boehringer Ingelheim Investigational Site Kumamoto, Kumamoto, Japan 1348.2.007 Boehringer Ingelheim Investigational Site Nakano-ku,Tokyo, Japan 1348.2.009 Boehringer Ingelheim Investigational Site Nishi-ku, Fukuoka, Fukuoka, Japan 1348.2.005 Boehringer Ingelheim Investigational Site Takatsuki, Osaka, Japan 1348.2.016 Boehringer Ingelheim Investigational Site Uji, Kyoto, Japan 1348.2.010 Boehringer Ingelheim Investigational Site Yoshikawa, Saitama, Japan Less <<
NCT02214966 Healthy Phase 1 Completed - -
NCT02262858 Healthy Phase 1 Completed - -
NCT02233218 Healthy Male Volunteer Phase 1 Completed - Korea, Republic of ... More >> Dong-A university hospital Pusan, Korea, Republic of Less <<
NCT02620163 Hypertension Phase 3 Completed - -
NCT02262598 Healthy Phase 1 Completed - -
NCT02269176 Hypertension Phase 3 Completed - -
NCT02262624 Healthy Phase 1 Completed - -
NCT02177435 Hypertension Phase 3 Completed - -
NCT02214979 Healthy Phase 1 Completed - -
NCT00890084 - Completed - -
NCT00890084 - Completed - -
NCT01911780 - Completed - -
NCT00865020 - Completed - -
NCT01278797 - Completed - -
NCT01278797 Hypertension Phase 1 Completed - Canada, Ontario ... More >> 1235.41.0001 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Less <<
NCT02242344 Hypertension Phase 2 Completed - -
NCT00926289 Hypertension Phase 4 Completed - -
NCT00926289 - Completed - -
NCT00865020 Hypertension Phase 4 Completed - Brazil ... More >> Investigative Site Sorocaba, Brazil Canada Investigative Site Gatineau, Canada Ecuador Investigative Site Guayaquil, Ecuador Germany Investigative Site Erfurt, Germany Hungary Invesitagtive Site Budapest, Hungary Korea, Republic of Investigative Site Cheongju, Korea, Republic of Malaysia Investigative Site Kuala Lumpur, Malaysia Mexico Investigative Site Mexico City, Mexico Panama Investigative Site Panama City, Panama Philippines Investigative Site Manila, Philippines Singapore Investigative Site Singapore, Singapore Slovakia Investigative Site Bratislava, Slovakia Spain Investigative Site Sevilla, Spain Turkey Investigative Site Istanbul, Turkey United Kingdom Investigative Site Westbury, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT00877929 Hypertension Phase 3 Completed - -
NCT00185705 Hypertension|Insulin Resistanc... More >>e|Dyslipidemia Less << TERMINATED 2025-07-07 Stanford Medical Center, Stanf... More >>ord, California, 94305-5401, United States Less <<
NCT02214992 Healthy Phase 1 Completed - -
NCT00877929 - Completed - -
NCT02951962 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT00509470 Essential Hypertension Phase 4 Completed - Japan ... More >> Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine Tokyo, Japan, 113-8655 Less <<
NCT02259777 Healthy Phase 1 Completed - -
NCT01180205 Hypertension Phase 4 Unknown October 2011 Germany ... More >> Universit?tsmedizin Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Less <<
NCT02261116 Healthy Phase 4 Completed - -
NCT02242812 Hypertension Phase 4 Terminated - -
NCT02152969 Hypertension Phase 1 Completed - Korea, Republic of ... More >> The Catholic University of Korea Seoul St.Mary's Hospital Seoul, Korea, Republic of Less <<
NCT02242370 Hypertension Phase 4 Completed - -
NCT02177487 Hypertension Phase 3 Completed - -
NCT00860262 - Completed - -
NCT00559286 Arterial Hypertension|Diabetes... More >> Mellitus Type 2 IRC or NIR Less << PHASE4 TERMINATED 2025-01-09 University Hospital, Aachen, N... More >>RW, 52074, Germany Less <<
NCT00860262 Hypertension Phase 3 Completed - -
NCT01224860 Renal Transplant Phase 2 Completed - Italy ... More >> Mario negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT00863980 Acute Myocardial Infarction ... More >> Angina Pectoris Myocardial Ischemia Acute Coronary Syndrome Hypertension Less << Not Applicable Terminated(Principle investiga... More >>tor resigned in 2013) Less << - Japan ... More >> Shakaihoken Kobe Central Hospital Kobe, Japan, 651-1145 Akashi Municipal Hospital Kobe, Japan, 673-8501 Kouseikai Takeda Hospital Kyoto, Japan, 600-8558 Aijyukai Dohjin Hospital Kyoto, Japan, 602-0917 Kyoto Second Red Cross Hospital Kyoto, Japan, 602-8026 Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Social Insurance Kyoto Hospital Kyoto, Japan, 603-8151 Kyoto Kojyo Hokenkai Kyoto, Japan, 604-8472 Kyoto City Hospital Kyoto, Japan, 604-8845 Kyoto First Red Cross Hospital Kyoto, Japan, 605-0981 Aiseikai Yamashina Hospital Kyoto, Japan, 607-8086 Tanabe Central Hospital Kyoto, Japan, 610-0334 Rakusai Simizu Hospital Kyoto, Japan, 610-1106 Uji Hospital Kyoto, Japan, 611-0011 Kyoto Yawata Hospital Kyoto, Japan, 614-8114 Seizinkai Simizu Hospital Kyoto, Japan, 615-8237 Saiseikai Kyoto Hospital Kyoto, Japan, 617-0814 Public Yamasiro Hospital Kyoto, Japan, 619-0214 Gakkentoshi Hospital Kyoto, Japan, 619-0238 Fukuchiyama City Hospital Kyoto, Japan, 620-8505 Ayabe City Hospital Kyoto, Japan, 623-0011 Maizuru Red Cross Hospital Kyoto, Japan, 624-0906 National Hospital Organization Maizuru Medical Center Kyoto, Japan, 625-8502 Maizuru Kyosai Hospital Kyoto, Japan, 625-8585 Public Nantan Hospital Kyoto, Japan, 629-0197 Kyoto Prefectural Yosanoumi Hospital Kyoto, Japan, 629-2261 Kumihama Hospital Kyoto, Japan, 629-3403 Sakurakai Takahashi Hospital Kyoto, Japan, 654-0026 Yuuseikai Midorigaoka Hospital Osaka, Japan, 569-1121 Matsushita Memorial Hospital Osaka, Japan, 570-8540 Saiseikai Shiga Hospital Shiga, Japan, 520-3046 Omihachiman Community Medical Center Shiga, Japan, 523-0892 Less <<
NCT00738660 Diabetic Nephropathy Phase 3 Completed - India ... More >> Post Graduate Institute of Medical Education and Research Chandigarh, India, 1600012 Less <<
NCT01204398 Hypertension Phase 3 Completed - China ... More >> 1235.31.86001 Boehringer Ingelheim Investigational Site Shanghai, China Less <<
NCT02255253 Hypertension Not Applicable Completed - China, Hebei ... More >> Chinese Traditional Medicine Hospital of Anguo Baoding, Hebei, China, 071200 Boye hospital Baoding, Hebei, China, 071300 Lixian chinese traditional medicine hospital Baoding, Hebei, China, 071400 Gaoyang hospital Baoding, Hebei, China, 071500 People's hospital in Rongcheng Baoding, Hebei, China, 071700 Mancheng Hospital Baoding, Hebei, China, 072150 Shunping Hospital Baoding, Hebei, China, 072250 People's hospital of Tangxian Baoding, Hebei, China, 072350 Wangdu hospital Baoding, Hebei, China, 072450 Gaobeidian hospital Baoding, Hebei, China, 074000 Central hospital in Baigou Baoding, Hebei, China, 074004 The second hospital of Lai Shui Baoding, Hebei, China, 074100 Wenan Hospital Lanfang, Hebei, China, 065800 Dacheng chinese traditional medicine hospital Langfang, Hebei, China, 065900 Less <<
NCT01204398 - Completed - -
NCT02231788 Hypertension Phase 4 Unknown April 2016 Korea, Republic of ... More >> Korea University Ansan Hospital Not yet recruiting Gyeonggi-do, Ansan-si, Korea, Republic of Contact: Sang Yeop Lim, Professor ?? +82-31-412-5366 ?? vnlover@daum.net ?? Jeju National University Hospital Recruiting Jeju, Aran, Korea, Republic of Contact: Seung-Jae Joo, Professor ?? +82-64-717-1701 ?? sejjoo@jejunu.ac.kr ?? Principal Investigator: Seung-Jae Joo, Professor ?? ?? ?? Bundang Cha Hospital Recruiting Seongnam, Bundang-gu, Korea, Republic of Contact: Sang-Uk Lim, Professor ?? +82-31-780-5852 ?? swlim@cha.ac.kr ?? Principal Investigator: Sang-Uk Lim, Professor ?? ?? ?? Seoul University Bundang Hospital Recruiting Seongnam, Bundang-gu, Korea, Republic of Contact: Chang-Hwan Yoon, Professor ?? +82-31-787-7032 ?? Kunson2@snu.ac.kr ?? Principal Investigator: Chang-Hwan Yoon, Professor ?? ?? ?? KyungHee University Medical Center Recruiting Seoul, Dongdaemun-gu, Korea, Republic of Contact: Jin-Bae Kim, Professor ?? +82-2-958-8176 ?? jinbbai@khu.ac.kr ?? Principal Investigator: Jin-Bae Kim, Professor ?? ?? ?? Gangnam Severance Hospital Recruiting Seoul, Gangnam-gu, Korea, Republic of Contact: Hyeok-Mun Kwon, Professor ?? +82-2-2019-3310 ?? kwonhm@yuhs.ac ?? Principal Investigator: Hyeok-Mun Kwon, Professor ?? ?? ?? Kumi cha Hospital Recruiting Gumi, Gyeongsangbuk-do, Korea, Republic of Contact: Hyeon-Sang Lee, Professor ?? +82-54-450-9551 ?? phd75602002@daum.net ?? Principal Investigator: Hyeon-Sang Lee, Professor ?? ?? ?? Seoul University Hospital Recruiting Seoul, Jongro-gu, Korea, Republic of Contact: Hyo-Soo Kim, Professor ?? +82-10-8393-2424 ?? usahyosoo@gmail.com ?? Principal Investigator: Hyo-Soo Kim, Professor ?? ?? ?? National Medical Center Recruiting Seoul, Jung-gu, Korea, Republic of Contact: Seung-Min Choi, Professor ?? +82-2-2260-7565 ?? choichoism@gmail.com ?? Principal Investigator: Seun-Min Choi, Professor ?? ?? ?? Kosin University Gospel Hospital Not yet recruiting Busan, Seo-gu, Korea, Republic of Contact: Hyoung Im Cho, Professor ?? +82-51-990-6105 ?? kyoungim74@gmail.com ?? Sejong Hospital Recruiting Bucheon, Wonmi, Korea, Republic of Contact: Yeong-Jin Choi, Professor ?? +82-32-340-1433 ?? cyjheart@gmail.com ?? Principal Investigator: Yeong-Jin Choi, Professor ?? ?? ?? Hallym University Kangnam Sacred Heart Hosipital Recruiting Seoul, Yeongdeungpo-gu, Korea, Republic of Contact: Nam-Ho Lee, Professor ?? +82-2-829-5395 ?? Namholee2@hotmail.com ?? Principal Investigator: Nam-Ho Lee, Professor Less <<
NCT02276391 Healthy Phase 1 Completed - -
NCT02526875 Hypertension Phase 4 Recruiting November 2017 Korea, Republic of ... More >> Korean University Guro Hospital Recruiting Seoul, Guro-gu, Korea, Republic of Contact: Jin-Won Kim ?? 82-2-2626-3021 ?? kjwmm@korea.ac.kr ?? Myongji Hospital Recruiting Goyang, Gyeonggi-di, Korea, Republic of Contact: Tae-Young Choi ?? 82-31-810-6773 ?? tchoicardio@gmail.com ?? Inje University Ilsan Paik Hospital Recruiting Goyang, Gyeonggi-do, Korea, Republic of Contact: Sung-Wook Kwon ?? 82-31-910-7041 ?? mdksu@yahoo.co.kr ?? Bundang Jesaeng Hospital Recruiting Seongnam, Gyeonggi-do, Korea, Republic of Contact: Sung-Wook Cho ?? 82-31-779-0379 ?? cswim@dmc.or.kr ?? Daegu Catholic University Medical Center Recruiting Dae-gu, Gyeongsangbuk-do, Korea, Republic of Contact: Young-Su Lee ?? 82-53-650-4797 ?? mdleeys@cu.ac.kr ?? Keimyung University Dongsan Medical Center Recruiting Daegu, Gyeongsangbuk-do, Korea, Republic of Contact: Hyeong-Seop Park ?? 82-53-250-7473 ?? drparkgyver@gmail.com ?? Yeungnam University Medical Center Recruiting Daegu, Gyeongsangbuk-do, Korea, Republic of Contact: Dong-Gu Shin ?? 82-53-620-3843 ?? dgshin@med.yu.ac.kr ?? Cheju Halla General Hospital Recruiting Jeju, Jeju Special Self-Governing, Korea, Republic of Contact: Seung-Ho Kang ?? 82-64-740-5002 ?? metronics@paran.com ?? Dong-A University Hospital Recruiting Busan, Seo-gu, Korea, Republic of Contact: Jong-Sung Park ?? 82-51-240-2764 ?? thinkmed@dau.ac.kr ?? Pusan National University Hospital Recruiting Busan, Seo-gu, Korea, Republic of Contact: Kwang-Su Cha ?? 82-51-240-7221 ?? chakws1@hanmail.net Less <<
NCT02183675 Healthy Phase 1 Completed - Japan ... More >> 1348.5.001 Boehringer Ingelheim Investigational Site Kanagawa , Yokohama, Japan Less <<
NCT00939588 Hypertension Phase 2 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00452192 Metabolic Syndrome PHASE3 COMPLETED 2025-12-09 Clinical Research Center, Depa... More >>rtment of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, 91054, Germany Less <<
NCT02183675 - Completed - -
NCT01435161 Atrial Fibrillation Phase 4 Completed - China, Chongqing ... More >> 2ndChongqingMU Chongqing, Chongqing, China, 400010 Less <<
NCT01271478 Inflammation ... More >>End-stage Renal Disease Less << Phase 4 Completed - Mexico ... More >> Hospital de Especialidades, CMNO, IMSS Guadalajara, Jalisco, Mexico, 44320 Less <<
NCT03226340 Essential Hypertension Phase 4 Recruiting March 31, 2018 Korea, Republic of ... More >> Hallym University Medical Center Recruiting Anyang, Dongan-gu, Korea, Republic of, 14068 Contact: Sang-Ho Jo ?? 82-31-380-3722 ?? sophi5neo@gmail.com ?? Kyung Hee University Hospital Recruiting Seoul, Dongdaemun-gu, Korea, Republic of, 02447 Contact: Soo-Joong Kim ?? 82-2-958-8180 ?? soojoong@dreamwiz.com ?? Hallym University Medical Center Recruiting Seoul, Gangdong-gu,, Korea, Republic of, 05355 Contact: Kyoo-Rok Han ?? 82-2-2224-2405 ?? krheart@hallym.or.kr ?? Samsung Medical Center Recruiting Seoul, Gangnam-Gu, Korea, Republic of, 06351 Contact: Sung-Ji Park ?? 82-2-3410-0887 ?? tyche.park@gmail.com ?? Korea Univ. Guro Hospital Recruiting Seoul, Guro, Korea, Republic of, 08308 Contact: Eung-ju Kim, MD,PhD ?? 82-8-2626-3022 ?? withnoel@empas.com ?? Seoul National University Hospital Recruiting Seoul, Jongno-gu, Korea, Republic of, 03080 Contact: Hyun-Jai Cho ?? 82-2-2072-3931 ?? hyunjaicho@snu.ac.kr ?? Hanyang University Medical Center Recruiting Seoul, Seongdong-gu, Korea, Republic of, 04763 Contact: Jin-Ho Shin ?? 82-2-2290-8308 ?? jhs2003@hanyang.ac.kr ?? Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: Jong-Min Song ?? 82-2-3010-3158 ?? jmsong@amc.seoul.kr ?? Ajou Univ. Medical Center Recruiting Suwon-si, Yeong-tong, Korea, Republic of, 16499 Contact: Joon-han Shin, MD,PhD ?? 82-31-219-5710 ?? shinjh@ajou.ac.kr ?? Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463707 Contact: Dong-Ju Choi, MD, PhD ?? 82-31-787-7007 ?? djchoi@snubh.org ?? Contact: Jin Joo Park, MD ?? 82-31-787 ext 7074 ?? jinjooparkmd@gmail.com Less <<
NCT02739672 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonbuk, Korea, Republic of, 561-712 Less <<
NCT02238262 Hypertension COMPLETED - -
NCT02259829 Healthy Phase 1 Completed - -
NCT02177422 Hypertension Phase 3 Completed - -
NCT00470886 - Completed - Poland ... More >> Many Locations, Poland Slovakia Many Locations, Slovakia Less <<
NCT02263989 Healthy Phase 1 Completed - -
NCT02215005 Healthy Phase 1 Completed - -
NCT01344629 Healthy Phase 1 Completed - Japan ... More >> 1235.28.001 Boehringer Ingelheim Investigational Site Kumamoto, Kumamoto, Japan Less <<
NCT02260089 Hypertension Phase 4 Completed - -
NCT03032315 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonbuk, Korea, Republic of, 561-712 Less <<
NCT02250833 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of, 700-721 Less <<
NCT01344629 - Completed - -
NCT00471003 - Completed - Croatia ... More >> Many Locations, Croatia Poland Many Locations, Poland Slovakia Many Locations, Slovakia Slovenia Many Locations, Slovenia Less <<
NCT02206659 Hypertension Phase 3 Completed - -
NCT02178306 Hypertension Phase 4 Completed - -
NCT01683084 Abdominal Aortic Aneurysm Phase 4 Completed - United States, California ... More >> VA Palo Alto Health Care System Palo Alto, California, United States, 94304 Less <<
NCT02187536 Healthy Phase 1 Completed - -
NCT02338232 GVHD TERMINATED 2023-01-05 Hackensack University Medical ... More >>Center, Hackensack, New Jersey, 07601, United States Less <<
NCT02261129 Healthy Phase 1 Completed - -
NCT01928927 HIV-1 Infection PHASE2 COMPLETED 2025-03-16 UCLA CARE Center CRS (601), Lo... More >>s Angeles, California, 90035, United States|University of Colorado Hospital CRS (6101), Aurora, Colorado, 80045, United States|Massachusetts General Hospital ACTG CRS (101), Boston, Massachusetts, 02114, United States|Washington U CRS (2101), Saint Louis, Missouri, 63110, United States|University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787), Rochester, New York, 14642, United States|Unc Aids Crs (3201), Chapel Hill, North Carolina, 27514, United States|Univ. of Cincinnati CRS (2401), Cincinnati, Ohio, 45267, United States|Case CRS (2501), Cleveland, Ohio, 44106, United States|Vanderbilt Therapeutics CRS (3652), Nashville, Tennessee, 37232, United States|Houston AIDS Research Team CRS (31473), Houston, Texas, 77030, United States|University of Washington AIDS CRS (1401), Seattle, Washington, 98104, United States|Puerto Rico-AIDS CRS (5401), San Juan, 00935, Puerto Rico Less <<
NCT02242838 Hypertension COMPLETED - -
NCT02047175 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> The catholic university of Korea, seoul ST.Mary's hospital Seoul, Gangnam-gu, Korea, Republic of Less <<
NCT01217879 - Completed - Slovakia ... More >> Many Locations, Slovakia Less <<
NCT02768948 Diabetic Nephropathy Not Applicable Recruiting July 2019 France ... More >> CHU de Nice Recruiting Nice, France, 06000 Contact: Guillaume FAVRE, PH ?? ?? favre.g@chu-nice.fr Less <<
NCT02387619 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System Seoul, Seodaemun-gu, Korea, Republic of, 120-752 Less <<
NCT01992601 Healthy Volunteer Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital, Yonsei University Seoul, Korea, Republic of, 120-752 Less <<
NCT01222520 Hypertension Phase 3 Completed - Japan ... More >> 1235.36.01 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1235.36.04 Boehringer Ingelheim Investigational Site Hiroshima, Hiroshima, Japan 1235.36.02 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1235.36.03 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan Less <<
NCT01222520 - Completed - -
NCT01928927 HIV-1 Infection PHASE2 COMPLETED 2025-03-16 UCLA CARE Center CRS (601), Lo... More >>s Angeles, California, 90035, United States|University of Colorado Hospital CRS (6101), Aurora, Colorado, 80045, United States|Massachusetts General Hospital ACTG CRS (101), Boston, Massachusetts, 02114, United States|Washington U CRS (2101), Saint Louis, Missouri, 63110, United States|University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787), Rochester, New York, 14642, United States|Unc Aids Crs (3201), Chapel Hill, North Carolina, 27514, United States|Univ. of Cincinnati CRS (2401), Cincinnati, Ohio, 45267, United States|Case CRS (2501), Cleveland, Ohio, 44106, United States|Vanderbilt Therapeutics CRS (3652), Nashville, Tennessee, 37232, United States|Houston AIDS Research Team CRS (31473), Houston, Texas, 77030, United States|University of Washington AIDS CRS (1401), Seattle, Washington, 98104, United States|Puerto Rico-AIDS CRS (5401), San Juan, 00935, Puerto Rico Less <<
NCT01975961 Dyslipidemia & Hypertension Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT03267329 Hypertension ... More >>Dyslipidemia Less << Phase 4 Not yet recruiting October 2018 Korea, Republic of ... More >> The Catholic University of Korea, Bucheon ST. Mary's Hospital Bucheon-si, Korea, Republic of Inje University Ilsan PAIK Hospital Goyang-si, Korea, Republic of KangBuk Samsung Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Yonsei University Health System, SEVERANCE HOSPITAL Seoul, Korea, Republic of Seoul National University, Bundang Hospital S?ngnam, Korea, Republic of Wonju Severance Christian Hospital W?nju, Korea, Republic of Less <<
NCT02738632 Essential Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02187705 - Completed - -
NCT01088295 HIV Infection PHASE2 COMPLETED 2025-06-11 UCLA CARE Center, Los Angeles,... More >> California, 90035, United States Less <<
NCT01088295 HIV Infection PHASE2 COMPLETED 2025-06-11 UCLA CARE Center, Los Angeles,... More >> California, 90035, United States Less <<
NCT02262559 Healthy Phase 1 Completed - -
NCT02750059 Acute HIV Infection ... More >> HIV CNS Involvement Less << Phase 2 Active, not recruiting December 2018 Thailand ... More >> SEARCH Thailand Bangkok, Thailand, 10330 Less <<
NCT01181011 - Completed - -
NCT02593110 Peripheral Artery Disease Not Applicable Recruiting April 2021 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathryn Domanchuk, BS ?? 312-503-6438 ?? k-domanchuk@northwestern.edu ?? Principal Investigator: Mary McDermott, MD ?? ?? ?? United States, Louisiana Tulane University Recruiting New Orleans, Louisiana, United States, 70112 Contact: Lydia Bazzano, MD ?? 504-842-4747 ?? lbazzano@tulane.edu ?? Contact: Shannon Terry ?? 504-988-7249 ?? sterry3@tulane.edu ?? Ochsner Medical Center Recruiting New Orleans, Louisiana, United States, 70121 Contact: Lydia Bazzano, MD ?? 504-842-4747 ?? lbazzano@tulane.edu ?? Contact: Grace Gartel ?? 504-897-5844 ?? ggartel@tulane.edu ?? Principal Investigator: Lydia Bazzano, MD Less <<
NCT03247140 Hypertension With Dyslipidemia Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of Less <<
NCT01211171 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT01806363 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook national university hospital Clionical center Daegu, Gyeongsangbuk-do, Korea, Republic of, 700-721 Less <<
NCT01181011 Healthy Phase 1 Completed - China ... More >> 1235.30.86001 Boehringer Ingelheim Investigational Site Shanghai, China Less <<
NCT02079805 Essential Hypertension Complic... More >>ated by Type 2 Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Kyoto-Shi, Kyoto, Japan Less <<
NCT03707899 Hypertension With Dyslipidemia Phase 1 Recruiting June 2019 Korea, Republic of ... More >> Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of Contact: Min Gul Kim, M.D., Ph D Less <<
NCT03566316 Hypertension With Hyperlipidem... More >>ia Less << Phase 3 Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT02259816 Healthy Phase 1 Completed - -
NCT03461081 Hypertension With Hyperlipidem... More >>ia Less << Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02085265 Alzheimer's Disease ... More >> Hypertension Less << Phase 2 Recruiting March 2021 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N1 Contact: Ramnik Sekhon ?? 403-210-7737 ?? ramnik.sekhon@ucalgary.ca ?? Contact: Anna Charlton ?? 403-210-6164 ?? acharlto@ucalgary.ca ?? Principal Investigator: Eric Smith, MD ?? ?? ?? University of Lethbridge Not yet recruiting Lethbridge, Alberta, Canada, T1K 6T5 Contact: Keiko McCreary, PhD ?? 403-394-3985 ?? keiko.mccreary2@uleth.ca ?? Principal Investigator: John Kennedy, MD ?? ?? ?? Principal Investigator: Robert Sutherland, PhD ?? ?? ?? Canada, British Columbia University of British Columbia Recruiting Vancouver, British Columbia, Canada, V6T 2B5 Contact: Mannie Fan ?? 604-822-0550 ?? mannie.fan@vch.ca ?? Principal Investigator: Robin Hsiung, MD ?? ?? ?? Canada, Ontario Hamilton General Hospital Recruiting Hamilton, Ontario, Canada, L8L 2X2 Contact: Ben Connolly ?? 289-440-1205 ?? connollyb@HHSC.CA ?? Principal Investigator: Demetrios (James) Sahlas, MD ?? ?? ?? Parkwood Institute Not yet recruiting London, Ontario, Canada, N6C 4R3 Principal Investigator: Michael Borrie, MD ?? ?? ?? South East Toronto Family Health Team Not yet recruiting Toronto, Ontario, Canada, M4C 5T2 Contact: Marcus Law, MD ?? 416.699.7775 ?? marcus.law@utoronto.ca ?? Principal Investigator: Marcus Law, MD ?? ?? ?? Centre for Memory and Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Contact: Mayrose Cornejo ?? 416-663-6897 ext 24 ?? mcornejo@memorycentre.ca ?? Contact: Josephine Accarrino ?? 416-663-6897 ext 21 ?? jaccarrino@memorycentre.ca ?? Principal Investigator: Giovanni Marotta, MD ?? ?? ?? Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Ferhana Dhira ?? 416-480-6103 ?? ferhana.dhira@sunnybrook.ca ?? Contact: Ljubica Zotovic ?? 416-480-6100 ext 3004 ?? ljubica.zotovic@sunnybrook.ca ?? Principal Investigator: Sandra Black, MD ?? ?? ?? St. Michael's Hospital Not yet recruiting Toronto, Ontario, Canada, M5B 1W8 Principal Investigator: Corinne Fischer, MD ?? ?? ?? Baycrest Health Sciences Not yet recruiting Toronto, Ontario, Canada, M6A 2E1 Contact: Brad Pugh ?? 406.785.2500 ext 6207 ?? b.pugh@baycrest.org ?? Principal Investigator: Morris Freedman, MD ?? ?? ?? Centre for Addiction and Mental Health (CAMH) Recruiting Toronto, Ontario, Canada Contact: Apoorva Bhandari ?? 416-535-8501 ext 33532 ?? Apoorva.Bhandari@camh.ca ?? Contact: Lina Chiuccariello ?? 416-535-8501 ext 30409 ?? Lina.Chiuccariello@camh.ca ?? Principal Investigator: Sanjeev Kumar, MD ?? ?? ?? University of Waterloo Not yet recruiting Waterloo, Ontario, Canada, N2L 3G1 Contact: Laura Middleton, PhD ?? 519-888-4567 ext 33045 ?? lmiddlet@uwaterloo.ca ?? Principal Investigator: Laura Middleton, PhD ?? ?? ?? Principal Investigator: George Heckman, MD Less <<
NCT01842230 Essential Hypertension ... More >> Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01578772 Endothelial Dysfunction PHASE2 COMPLETED 2025-03-13 UCLA CARE Center, Los Angeles,... More >> California, 90035, United States Less <<
NCT01578772 Endothelial Dysfunction PHASE2 COMPLETED 2025-03-13 UCLA CARE Center, Los Angeles,... More >> California, 90035, United States Less <<
NCT02057328 Hypertension Phase 4 Unknown January 2017 Greece ... More >> Hypertension-ABPM Center 3rd department of Internal Medicine Recruiting Thessaloniki, Greece Contact: Vasilios Kotsis, MD, Ph.D ?? +306974748860 ?? vkotsis@auth.gr ?? Principal Investigator: Sofia Papakatsika, MD Less <<
NCT02079805 - Completed - -
NCT01356017 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT03705533 Bioequivalence Phase 1 Recruiting December 2, 2018 Canada, Quebec ... More >> Algorithme Pharma, An Altasciences Company Recruiting Mount-Royal, Quebec, Canada, H3P 3P1 Contact: Irina Mosesova ?? 514 466-0284 ?? imosesova@altasciences.com Less <<
NCT02213224 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Less << Phase 4 Unknown September 2017 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting GuangZhou, Guangdong, China, 510515 Contact: Yue Li, MD ?? +86-15975537291 ?? liyue_1989919@126.com ?? Principal Investigator: Side Liu, MD.PhD ?? ?? ?? Sub-Investigator: Yue Li, MD ?? ?? ?? Sub-Investigator: Xu Li, MD ?? ?? ?? Sub-Investigator: Zelong Han, MD ?? ?? ?? Sub-Investigator: Wen Xu, MM ?? ?? ?? Sub-Investigator: Yubin Guo, MM ?? ?? ?? Sub-Investigator: Feng Xiong, MD Less <<
NCT02170246 Acute HIV Infection|HIV Infect... More >>ions Less << PHASE1 COMPLETED 2018-06-13 Chulalongkorn University Hospi... More >>tal, Bangkok, 10330, Thailand|Thai Red Cross AIDS Research Centre, Bangkok, 10330, Thailand Less <<
NCT01992796 Severe Sepsis Phase 3 Unknown January 2017 Italy ... More >> Università di Salerno Not yet recruiting Salerno, Italy Contact: Ornella Piazza ?? ?? ?? Principal Investigator: Ornella Piazza Less <<
NCT00741585 Essential Hypertension ... More >> Cardiovascular Disease Stroke Chronic Kidney Disease Less << Phase 4 Completed - Spain ... More >> CS Friol Friol, Lugo, Spain, 27220 CS Baiona Baiona, Pontevedra, Spain, 36300 CS Bueu Bueu, Pontevedra, Spain, 36930 CS A Estrada La Estrada, Pontevedra, Spain, 26680 CS A Guarda La Guardia, Pontevedra, Spain, 36780 CS Valmi?or Nigran, Pontevedra, Spain, 36250 CS Panxón Nigrán, Pontevedra, Spain, 36340 CS Tomi?o Tomi?o, Pontevedra, Spain, 36200 Bioengineering & Chronobilogy Labs., University of Vigo Vigo, Pontevedra, Spain, 36200 Hospital do Meixoeiro Vigo, Pontevedra, Spain, 36200 CS Calle Cuba Vigo, Pontevedra, Spain, 36202 CS A Doblada Vigo, Pontevedra, Spain, 36205 CS Coia Vigo, Pontevedra, Spain, 36209 CS Sardoma Vigo, Pontevedra, Spain, 36214 CS Teis Vigo, Pontevedra, Spain, 36216 CS Vilaboa Vilaboa, Pontevedra, Spain, 36141 CS San Roque Vilagarcía De Arousa, Pontevedra, Spain, 36600 CS Fingoi Lugo, Spain, 27002 Complexo Hospitalario Universitario de Ourense Orense, Spain, 32005 CS Lerez Pontevedra, Spain, 36156 Less <<
NCT00295542 Hypertension Phase 4 Completed - Spain ... More >> Hospital Clinico Universitario Santiago de Compostela, Spain, 15706 Less <<
NCT01715584 Hypertension Phase 4 Recruiting December 31, 2019 Canada, Ontario ... More >> London Health Sciences Centre - Victoria Campus Recruiting London, Ontario, Canada, N6A 5W9 Contact: Craig J Railton, MD, PhD ?? 519 685 8500 ext 58525 ?? Craig.Railton@lhsc.on.ca ?? Principal Investigator: Craig J Railton, MD, PhD ?? ?? ?? Sub-Investigator: Jonathan Fairbairn, BSc ?? ?? ?? Sub-Investigator: George Nicoloau, MD ?? ?? ?? Sub-Investigator: Robert Gros, PhD ?? ?? ?? Sub-Investigator: Jason Franklin, MD ?? ?? ?? Sub-Investigator: John Yoo, MD ?? ?? ?? Sub-Investigator: Kevin Fung, MD ?? ?? ?? Sub-Investigator: Anthony Nichols, MD ?? ?? ?? Sub-Investigator: Danielle McNeil, MD Less <<
NCT00670787 Hypertension Phase 3 Completed - Japan ... More >> Department of Medicine and Clinical Science, Kyushu University Fukuoka City, Fukuoka, Japan, 812-8582 Less <<
NCT03319823 High Blood Pressure Phase 4 Recruiting December 1, 2018 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Katie Sy ?? 310-248-7641 ?? katrina.sy@cshs.org ?? Principal Investigator: Ronald G Victor, MD Less <<
NCT01377285 Chronic Renal Failure Phase 4 Unknown December 2018 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tun-Jun Tsai, M.D.; PhD ?? 00886-2-23123456 ext 63953 ?? tjtsai@ntuh.gov.tw ?? Contact: Yung-Ming Chen, M.D. ?? 00886-2-23123456 ext 65993 ?? chenym@ntuh.gov.tw ?? Principal Investigator: Tun-Jun Tsai, M.D.; PhD Less <<
NCT00421863 Hypertension Phase 4 Completed - Italy ... More >> Ospedale N. Melli San Pietro Vernotico, Brindisi, Italy, 72027 Ospedale Civile Mellini Chiari, BS, Italy, 25032 Ospedale Civile G. Chidichimo Trebisacce, Cosenza, Italy, 87075 Istituto Neuromed Pozzilli, Isernia, Italy, 86077 Presidio Ospedaliero F. Ferrari Casarano, Lecce, Italy, 73042 Nuovo Ospedale Versilia Lido di Camaiore, Lucca, Italy, 55043 Ospedale Civile Castiglione del Lago, Perugia, Italy, 06061 Ospedale Civile Beato Giacomo Villa Città della Pieve, Perugia, Italy, 06062 Presidio Ospedaliero Città di Castello Città di Castello, Perugia, Italy, 06012 Ospedale Civile Gubbio, Perugia, Italy, 06024 Presidio Ospedaliero Todi, Perugia, Italy, 06059 Ospedale Silvestrini Perugia, PG, Italy Ospedale Civile Sacile, Pordenone, Italy, 33077 Ospedale Scillesi D'America Scilla, Reggio Calabria, Italy, 89058 Ospedale Civile Thiesi, Sassari, Italy, 07047 Presidio Ospedaliero Poggibonsi, Siena, Italy, 53034 Ospedale Civile S. Antonio Abate Erice, Trapani, Italy, 91016 Ospedale S. Antonio San Daniele del Friuli, Udine, Italy, 33038 Ospedale Generale Regionale Aosta, Italy, 11100 Azienda Ospedaliera G. Rummo Benevento, Italy, 82100 Spedali Civili Brescia, Italy, 25123 Azienda Ospedaliera G. Brotzu - S. Michele Cagliari, Italy, 09134 Ospedale S. Elia Caltanissetta, Italy, 93100 Ospedale Garibaldi-Nesima Catania, Italy, 95122 Azienda Ospedaliera Mater Domini Catanzaro, Italy, 88100 Ospedale Clinicizzato Santissima Annunziata Chieti, Italy, 66013 Istituti Ospitalieri Cremona, Italy, 26100 Dimi - Disem Genova, Italy, 16132 Ospedale Generale Provinciale Gorizia, Italy, 34170 Policlinico Universitario Federico II Napoli, Italy, 80131 Azienda Ospedaliera di Perugia Perugia, Italy, 06132 Spedali Riuniti Pistoia, Italy, 51100 Ospedale Civile Ragusa, Italy, 97100 Ospedali Riuniti G. Melacrino F. Bianchi Reggio Calabria, Italy, 89124 Ospedale San Filippo Neri Roma, Italy, 00135 CTO Roma, Italy, 00145 Ospedlae San Camillo Roma, Italy, 00149 Ospedale San Camillo Roma, Italy, 00152 Ospedale San Giovanni Roma, Italy, 00184 Policlinico Universitario Sassari, Italy, 07100 Azienda Ospedaliera Siracusa, Italy, 96100 Azienda USL 4 Terni Terni, Italy, 05100 Ospedale San Vito Torino, Italy, 10134 Casa di Cura Villa Bianca Trento, Italy, 38100 Ospedale Belcolle Viterbo, Italy, 01100 Less <<
NCT01853839 - Completed - -
NCT00684489 Hypertension Not Applicable Completed - -
NCT01853839 - Completed - -
NCT01198496 Hypertension ... More >>Stroke Blood Pressure Less << Phase 4 Recruiting December 2019 Japan ... More >> Jichi Medical Univercity Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Kazuyuki Shimada, MD ?? ?? kazuyuki@jichi.ac.jp ?? Principal Investigator: Kazuomi Kario, MD Less <<
NCT00528385 Chronic Kidney Disease ... More >> Proteinuria Less << Not Applicable Completed - -
NCT01353274 - Completed - -
NCT01353274 - Completed - -
NCT03067688 Hypertension ... More >>Hyperlipidemia Less << Phase 3 Recruiting February 2018 Korea, Republic of ... More >> Seoul Natuional University Hospital Recruiting Seoul, Jongno, Korea, Republic of, 03080 Contact: Hyosoo Kim, PhD Less <<
NCT03504566 Diabetic Nephropathy Type 2 Phase 4 Withdrawn(Registered and publi... More >>shed incorrectly) Less << June 1, 2019 Denmark ... More >> Steno Diabetes Center Copenhagen Gentofte, Denmark, 2820 Less <<
NCT00361023 Type 2 Diabetes ... More >> Diabetic Nephropathy Less << Not Applicable Completed - -
NCT00283686 Kidney, Polycystic Phase 3 Completed - United States, Colorado ... More >> University of Colorado Health Sciences Center Denver (Aurora), Colorado, United States, 800045 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Tufts University-New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT01050062 - Completed - -
NCT00283686 - Completed - -
NCT01050062 - Completed - -
NCT00221845 Children Chro... More >>nic Renal Failure Hypertension Acquired Kidney Disease Congenital Kidney Disease Less << Phase 3 Completed - -
NCT00905528 - Completed - Germany ... More >> University of Erlangen-Nuremberg Erlangen, Bavaria, Germany, 91054 Less <<
NCT02496910 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT01996085 Arterial Hypertension Not Applicable Completed - Poland ... More >> Military Institute of Medicine Warsaw, Mazovia, Poland, 04-141 Less <<
NCT02248896 - Completed - -
NCT03021265 - Active, not recruiting April 30, 2019 Japan ... More >> Nippon Boehringer Ingelheim Co., Ltd Tokyo, Japan, 4570047 Less <<
NCT00562952 Diabetes Mellitus ... More >> Heart Failure Coronary Artery Disease Less << Phase 2 Phase 3 Completed - Austria ... More >> General Hospital of Vienna Department of Endocrinology Vienna, Austria, 1090 Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT02243566 - Completed - -
NCT00558064 Hypertension Phase 3 Completed - Japan ... More >> 1235.13.037 Boehringer Ingelheim Investigational Site Azumino, Nagano, Japan 1235.13.023 Boehringer Ingelheim Investigational Site Higashiosaka, Osaka, Japan 1235.13.021 Boehringer Ingelheim Investigational Site Itabashi-ku, Tokyo, Japan 1235.13.014 Boehringer Ingelheim Investigational Site Kashihara, Osaka, Japan 1235.13.038 Boehringer Ingelheim Investigational Site Kitaazumi-gun, Nagano, Japan 1235.13.009 Boehringer Ingelheim Investigational Site Kiyose, Tokyo, Japan 1235.13.041 Boehringer Ingelheim Investigational Site Kobe, Hyogo, Japan 1235.13.035 Boehringer Ingelheim Investigational Site Komoro, Nagano, Japan 1235.13.003 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.004 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.027 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1235.13.007 Boehringer Ingelheim Investigational Site Koshigaya, Saitama,, Japan 1235.13.008 Boehringer Ingelheim Investigational Site Koto-ku, Tokyo, Japan 1235.13.005 Boehringer Ingelheim Investigational Site Matsudo, Chiba, Japan 1235.13.026 Boehringer Ingelheim Investigational Site Mito, Ibaraki, Japan 1235.13.013 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1235.13.016 Boehringer Ingelheim Investigational Site Okayama, Okayama,, Japan 1235.13.040 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1235.13.025 Boehringer Ingelheim Investigational Site Saitama, Saitama, Japan 1235.13.001 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.024 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.028 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.030 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.031 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.033 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.034 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1235.13.002 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.018 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.019 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1235.13.036 Boehringer Ingelheim Investigational Site Shimoina-gun, Nagano, Japan 1235.13.042 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1235.13.010 Boehringer Ingelheim Investigational Site Shinjyuku-ku, Tokyo, Japan 1235.13.011 Boehringer Ingelheim Investigational Site Shinjyuku-ku,Tokyo, Japan 1235.13.022 Boehringer Ingelheim Investigational Site Shizuoka, Shizuoka, Japan 1235.13.015 Boehringer Ingelheim Investigational Site Suita, Osaka,, Japan 1235.13.017 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.029 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.032 Boehringer Ingelheim Investigational Site Takamatsu, Kagawa, Japan 1235.13.012 Boehringer Ingelheim Investigational Site Takaoka, Toyama, Japan 1235.13.039 Boehringer Ingelheim Investigational Site Takaoka,Toyama, Japan 1235.13.020 Boehringer Ingelheim Investigational Site Tsuchiura, Ibaraki, Japan Less <<
NCT02699645 Acute Intracerebral Haemorrhag... More >>e (ICH) Hypertension Less << Phase 3 Recruiting December 2023 -
NCT01885559 - Completed - -
NCT02262611 - Completed - -
NCT00659607 - Completed - -
NCT01885559 Kidney, Polycystic Phase 3 Completed - United States, Colorado ... More >> University of Colorado Health Sciences Center Denver (Aurora), Colorado, United States, 800045 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Tufts University-New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT01071681 - Completed - France ... More >> Many Locations, France Less <<
NCT00274144 Hypertension ... More >>Coronary Arteriosclerosis Less << Phase 4 Completed - Germany ... More >> Universit?tsklinik des Saarlandes Homburg/Saar, Germany, 66421 Less <<
NCT00558064 - Completed - -
NCT00659607 - Completed - -
NCT03438955 Hyperlipidemia, Hypertriglycer... More >>idemia Less << Phase 1 Recruiting August 31, 2018 Korea, Republic of ... More >> Dong-A National University Hospital Recruiting Busan, Korea, Republic of, 49201 Contact: Min Kyu Park Less <<
NCT00926341 Metabolic Syndrome Phase 4 Completed - India ... More >> Department of Medicine, J.N.Medical,College, AMU,Aligarh Aligarh, Uttar Pradesh, India, 202002 Less <<
NCT03210532 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Sevrance Hospital Seoul, Korea, Republic of Less <<
NCT02215733 - Completed - -
NCT02373163 Blood Pressure, High Phase 4 Unknown June 2016 Peru ... More >> Centro de Investigacion PREVENCION Recruiting Arequipa, AQP, Peru Contact: Josefina E Medina-Lezama, MD ?? +5154251269 ?? Josefina Medina Less <<
NCT00936208 - Completed - -
NCT01246193 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Inje Unuversity Pusan Paik Hospital Pusan, Korea, Republic of Less <<
NCT02202525 - Completed - -
NCT01634295 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul national university Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Less <<
NCT00486187 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Partners Research Brampton, Ontario, Canada, L6V 1B4 Less <<
NCT01983735 Hypertension Phase 3 Unknown August 2014 Korea, Republic of ... More >> The catholic university of Korea Seoul St. Mary's hospital Not yet recruiting Seoul, Korea, Republic of Contact: Ho-Joong Yoon, Ph.D ?? 82-2-2258-6029 ?? younhj@catholic.ac.kr ?? Principal Investigator: Ho-Joong Yoon, Ph.D Less <<
NCT01011660 Essential Hypertension Phase 4 Unknown December 2012 China, Beijing ... More >> Wang Wen Recruiting Beijing, Beijing, China, 100037 Contact: Liyuan Ma ?? 86 10 68335002 ?? maliyuan600@vip.sina.com ?? Principal Investigator: Wen Wang Less <<
NCT01541267 Chronic Kidney Disease ... More >> Proteinuria Less << Phase 4 Completed - -
NCT00615108 - Completed - Taiwan ... More >> Boehringer Ingelheim Investigator Site Changhua, Taiwan Boehringer Ingelheim Investigator Site 1 Chiayi, Taiwan Boehringer Ingelheim Investigator Site 2 Chiayi, Taiwan Boehringer Ingelheim Investigator Site Keelung, Taiwan Boehringer Ingelheim Investigator Site Ksohsiung, Taiwan Boehringer Ingelheim Investigator Site Miaoli, Taiwan Boehringer Ingelheim Investigator Site 1 Taichung, Taiwan Boehringer Ingelheim Investigator Site 2 Taichung, Taiwan Boehringer Ingelheim Investigator Site 1 Tainan, Taiwan Boehringer Ingelheim Investigator Site 2 Tainan, Taiwan Boehringer Ingelheim Investigator Site 1 Taipei, Taiwan Boehringer Ingelheim Investigator Site 2 Taipei, Taiwan Boehringer Ingelheim Investigator Site 3 Taipei, Taiwan Boehringer Ingelheim Investigator Site 4 Taipei, Taiwan Boehringer Ingelheim Investigator Site 5 Taipei, Taiwan Boehringer Ingelheim Investigator Site 6 Taipei, Taiwan Boehringer Ingelheim Investigator Site 7 Taipei, Taiwan Less <<
NCT02968160 Metabolic Syndrome Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Dongguk University Medical Center Recruiting Ilsan, Korea, Republic of, 10326 Less <<
NCT01748253 Hypertension and Atrial Fibril... More >>lation Less << Not Applicable Unknown - Japan ... More >> Uchiyama Clinic Recruiting Joetsu city, Niigata pref., Japan Contact: Kazuaki Uchiyama ?? +81‐25‐548‐2400 Less <<
NCT02242331 - Completed - -
NCT00936208 - Completed - -
NCT00239538 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT03662620 Hypertension Phase 1 Not yet recruiting December 23, 2018 -
NCT01316419 - Completed - -
NCT01352689 Hypertension Phase 1 Completed - -
NCT02933658 Hypertension and Dyslipidemia Phase 1 Completed - -
NCT01340131 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Inje University Pusan Paik Hospital Pusan, Korea, Republic of Less <<
NCT01501253 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul St. Mary's hospital, The catholic university of Korea Seoul, Korea, Republic of Less <<
NCT02242383 - Completed - -
NCT01128322 Hypertension Phase 2 Completed - Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Soonchunhyang University Hospital in Bucheon Bucheon, Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of Chungbuk National Uiversity Hospital Cheongju, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of DonGuk University International Hospital Goyang, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Goyang, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Gachon University Gil Medical Center Inchon, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Ewha Womans University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Kandong Sacred Heart Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Seoul St. Mary's Hospital, The catholic University of Korea Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of SMG-SNU Boramae Medical Center Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul, Korea, Republic of St. Paul's Hospital, The catholic University of Korea Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Uijeongbu St. Mary's Hospital, The catholic University of Korea Uijeongbu, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT03550859 Chronic Kidney Disease ... More >> Proteinuria Less << Phase 4 Not yet recruiting June 2019 Korea, Republic of ... More >> Korea University Ansan Hospital Not yet recruiting Ansan, Korea, Republic of Less <<
NCT01316419 - Completed - -
NCT00615108 - Completed - -
NCT00242814 Hypertension ... More >>Metabolic Syndrome X Less << Phase 4 Completed - France ... More >> 502.486.3302A Cabinet Médical Angers, France 502.486.3302B Cabinet Médical Angers, France 502.486.3303A Boehringer Ingelheim Investigational Site Angers, France 502.486.3305A Cabinet Médical Angers, France 502.486.3323A Cabinet Médical Angers, France 502.486.3323B Cabinet Médical Angers, France 502.486.3324A Cabinet Médical Angers, France 502.486.3324B Cabinet Médical Angers, France 502.486.3325A Cabinet médical Angers, France 502.486.3326A Cabinet Médical Angers, France 502.486.3328A Cabinet Médical Angers, France 502.486.3306A Cabinet Médical Briollay, France 502.486.3307A Cabinet Médical Chemille, France 502.486.3319A Cabinet Médical Cherbourg, France 502.486.3320A Cabinet Médical Cherbourg, France 502.486.3320B Cabinet Médical Cherbourg, France 502.486.3321A Cabinet Médical Equeurdreville, France 502.486.3322A Boehringer Ingelheim Investigational Site Evron, France 502.486.3312A Cabinet Médical Feneu, France 502.486.3315A Cabinet Médical La Rochelle, France 502.486.3308A Cabinet Médical Montrevault, France 502.486.3316A Boehringer Ingelheim Investigational Site Nieul sur Mer, France 502.486 3301A Boehringer Ingelheim Investigational Site Paris, France 502.486.3301B H?pital Pitié Salpêtrière Paris, France 502.486.3310A Cabinet Médical Saint Pierre Montlimard, France 502.486.3327A Cabinet Médical Saumur, France 502.486.3309A Cabinet Médical Jean Charcot Segre, France 502.486.3311A Cabinet Médical Tierce, France 502.486.3311B Cabinet Médical Tierce, France 502.486.3311C Cabinet Médical Tierce, France 502.486.3311D Cabinet Médical Tierce, France Less <<
NCT00904371 - Completed - Slovenia ... More >> Boehringer Ingelheim Investigational Site 24 Brezice, Slovenia Boehringer Ingelheim Investigational Site 2 Brezice, Slovenia Boehringer Ingelheim Investigational Site 12 Celje, Slovenia Boehringer Ingelheim Investigational Site 16 Celje, Slovenia Boehringer Ingelheim Investigational Site 17 Celje, Slovenia Boehringer Ingelheim Investigational Site 1 Celje, Slovenia Boehringer Ingelheim Investigational Site 33 Celje, Slovenia Boehringer Ingelheim Investigational Site 18 Golnik, Slovenia Boehringer Ingelheim Investigational Site 23 Golnik, Slovenia Boehringer Ingelheim Investigational Site 29 Golnik, Slovenia Boehringer Ingelheim Investigational Site 32 Golnik, Slovenia Boehringer Ingelheim Investigational Site 15 Jesenice, Slovenia Boehringer Ingelheim Investigational Site 4 Kranj, Slovenia Boehringer Ingelheim Investigational Site 28 Litija, Slovenia Boehringer Ingelheim Investigational Site 26 Ljubljana, Slovenia Boehringer Ingelheim Investigational Site 35 Ljubljana, Slovenia Boehringer Ingelheim Investigational Site 3 Ljubljana, Slovenia Boehringer Ingelheim Investigational Site 6 Ljubljana, Slovenia Boehringer Ingelheim Investigational Site 14 Maribor, Slovenia Boehringer Ingelheim Investigational Site 22 Maribor, Slovenia Boehringer Ingelheim Investigational Site 20 Murska Sobota, Slovenia Boehringer Ingelheim Investigational Site 27 Murska Sobota, Slovenia Boehringer Ingelheim Investigational Site 31 Murska Sobota, Slovenia Boehringer Ingelheim Investigational Site 11 Novo mesto, Slovenia Boehringer Ingelheim Investigational Site 19 Novo mesto, Slovenia Boehringer Ingelheim Investigational Site 21 Novo mesto, Slovenia Boehringer Ingelheim Investigational Site 9 Novo mesto, Slovenia Boehringer Ingelheim Investigational Site 25 Sempeter, Slovenia Boehringer Ingelheim Investigational Site 30 Sempeter, Slovenia Boehringer Ingelheim Investigational Site 34 Sezana, Slovenia Boehringer Ingelheim Investigational Site 10 Slovenj Gradec, Slovenia Boehringer Ingelheim Investigational Site 36 Slovenj Gradec, Slovenia Boehringer Ingelheim Investigational Site 13 Topolsica, Slovenia Boehringer Ingelheim Investigational Site 5 Trbovlje, Slovenia Boehringer Ingelheim Investigational Site 8 Trbovlje, Slovenia Boehringer Ingelheim Investigational Site 7 Velenje, Slovenia Less <<
NCT01243268 - Completed - Korea, Republic of ... More >> NISND Center One Or Multiple Sites, Korea, Republic of Less <<
NCT00904371 - Completed - -
NCT00847262 Hypertension ... More >>Obesity Diabetes Less << Phase 4 Completed - China ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, China, 400042 Less <<
NCT00274105 Hypertension ... More >>Coronary Arteriosclerosis Less << Phase 4 Terminated - Germany ... More >> Universit?tsklinikum Charité Berlin, Germany, 10117 Med. Hochschule Hannover Hannover, Germany, 30623 Less <<
NCT01108796 - Completed - -
NCT01108796 - Completed - -
NCT00909038 - Completed - -
NCT02242825 - Completed - -
NCT02242864 - Completed - -
NCT00909038 - Completed - -
NCT00558428 Hypertension Phase 3 Completed - -
NCT01103960 Hypertension Phase 3 Completed - China ... More >> 1235.29.86001 Boehringer Ingelheim Investigational Site Beijing, China 1235.29.86004 Boehringer Ingelheim Investigational Site Beijing, China 1235.29.86006 Boehringer Ingelheim Investigational Site Changchun, China 1235.29.86013 Boehringer Ingelheim Investigational Site Changsha, China 1235.29.86014 Boehringer Ingelheim Investigational Site Guangzhou, China 1235.29.86012 Boehringer Ingelheim Investigational Site Hangzhou, China 1235.29.86002 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86009 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86010 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86011 Boehringer Ingelheim Investigational Site Shanghai, China 1235.29.86007 Boehringer Ingelheim Investigational Site Shenyang, China 1235.29.86008 Boehringer Ingelheim Investigational Site Tianjin, China Malaysia 1235.29.60017 Boehringer Ingelheim Investigational Site Johor, Malaysia 1235.29.60016 Boehringer Ingelheim Investigational Site Kuala Lumpur, Malaysia Philippines 1235.29.63018 Boehringer Ingelheim Investigational Site Metro Manila, Philippines 1235.29.63019 Boehringer Ingelheim Investigational Site Quezon City, Philippines Less <<
NCT00558428 - Completed - -
NCT00613314 - Completed - -
NCT01103960 - Completed - -
NCT00274118 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 3 Completed - Denmark ... More >> Boehringer Ingelheim Investigational Site Frederiksberg C, Denmark, DK-1900 Apopleksiafsnittet Frederiksberg, Denmark, DK-2000 Lungemedicinsk Forskning Hellerup, Denmark, DK-2900 Medical Dept. B0642 Hiller?d, Denmark, DK-3400 Hvidovre Hospital Hvidovre, Denmark, DK-2650 Gyn?kologisk/obstetrisk afd. Kolding, Denmark, 6000 Finland Boehringer Ingelheim Investigational Site Hyvink??, Finland, 05850 Boehringer Ingelheim Investigational Site Jyv?skyl?, Finland, FIN-40100 Kuopion yliopistollinen sairaala, Keuhkoklinikka Kuopio, Finland, FI-70211 Boehringer Ingelheim Investigational Site Riihim?ki, Finland, 11100 Boehringer Ingelheim Investigational Site Tampere, Finland, 33520 Netherlands Bosch Medicentrum Den Bosch, Netherlands, 5223 GV Dept. of Internal Medicine Utrecht, Netherlands, 3584 CX Norway Boehringer Ingelheim Investigational Site Arendal, Norway, N-4841 Boehringer Ingelheim Investigational Site Jessheim, Norway, N-2050 Boehringer Ingelheim Investigational Site Skogn, Norway, N-7620 Hjertelaget Research Foundation Stavanger, Norway, N-4011 Sweden Medicinkliniken Eksj?, Sweden, 575 81 Medicinkliniken Helsingborg, Sweden, 251 87 Boehringer Ingelheim Investigational Site Helsingborg, Sweden, 254 67 Boehringer Ingelheim Investigational Site Munkedal, Sweden, 455 30 Boehringer Ingelheim Investigational Site Tran?s, Sweden, 573 83 Boehringer Ingelheim Investigational Site Uddevalla, Sweden, 451 40 Samariterhemmets sjukhus Uppsala, Sweden, 751 25 Boehringer Ingelheim Investigational Site Vetlanda, Sweden, 574 28 United Kingdom Boehringer Ingelheim Investigational Site Atherstone, United Kingdom, CV9 1EU Boehringer Ingelheim Investigational Site Barry, United Kingdom, CF62 7EB Dept. of Diabetes Birmingham, United Kingdom, B18 7QH Department of Respiratory Medicine Birmingham, United Kingdom, B9 5SS Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Finance Office (Research Unit) Newcastle-Upon-Tyne, United Kingdom, NE1 7RU Northampton General Hospital Northampton, United Kingdom, NN1 5BD Boehringer Ingelheim Investigational Site Northampton, United Kingdom, NN5 7AQ Diabetes Centre, Nuneaton,, United Kingdom, CV10 7DJ Lucille Packard Children's Health Services at Stanford Palo Alto, United Kingdom, 94304-5786 Boehringer Ingelheim Investigational Site Pontyclun, United Kingdom, CF72 9AA Diabetes Centre Rugby, United Kingdom, CV22 5PX Less <<
NCT00613314 - Completed - -
NCT00539487 - Completed - -
NCT00146289 Obesity Insul... More >>in Resistance Less << Phase 2 Completed - United States, California ... More >> UCLA School of Medicine- Divison of Endocrinology Los Angeles, California, United States University of CA at SanDiego- Department of Endocrinology San Diego, California, United States Boehringer Ingelheim Investigational Site Westlake Village, California, United States United States, Illinois Boehringer Ingelheim Investigational Site Chicago, Illinois, United States United States, New York University of Rochester Medical Center Rochester, New York, United States United States, Ohio Boehringer Ingelheim Investigational Site Cincinnati, Ohio, United States United States, Tennessee Boehringer Ingelheim Investigational Site Nashville, Tennessee, United States United States, Texas Boehringer Ingelheim Investigational Site Harker Heights, Texas, United States Canada, Manitoba University of Manitoba, Diabetes Research Group Winnipeg, Manitoba, Canada Canada, Ontario St. Joseph's Health Care London London, Ontario, Canada The Ottawa Hospital - Riverside Campus Ottawa, Ontario, Canada Denmark ?rhus Sygehus Aarhus C, Denmark Germany Universit?tsmedizin Berlin Berlin, Germany Boehringer Ingelheim Investigational Site Künzing, Germany Boehringer Ingelheim Investigational Site Unterschneidheim, Germany Italy Policlinico Monteluce Perugia, Italy Azienda Ospedale Università di Pisa Pisa, Italy Less <<
NCT00153062 Stroke Phase 4 Completed - -
NCT00638911 - Completed - -
NCT00982735 - Completed - -
NCT02177448 Hypertension Phase 3 Completed - -
NCT02200575 Hypertension COMPLETED - -
NCT00168779 Hypertension Phase 4 Completed - -
NCT01243268 - Completed - -
NCT02242357 - Completed - -
NCT00240448 Hypertension Phase 4 Completed - -
NCT02238275 - Completed - -
NCT00274638 Hypertension Phase 4 Completed - -
NCT03742544 - Enrolling by invitation October 30, 2020 -
NCT00153062 - Completed - -
NCT00982735 - Completed - -
NCT02242851 Hypertension COMPLETED - -
NCT04736329 Heart Failure With Reduced Eje... More >>ction Fraction|Renal Insufficiency Less << COMPLETED 2022-10-31 Kasralainy hospital, faculty o... More >>f medicine, Cairo university, Cairo, 11562, Egypt Less <<
NCT00659581 Hypertension COMPLETED - -
NCT06815497 Ovarian Cancer PHASE2 NOT_YET_RECRUITING 2029-05-14 Dartmouth Hitchcock, Lebanon, ... More >>New Hampshire, 03756, United States Less <<
NCT02245464 Hypertension COMPLETED - -
NCT04510662 COVID-19|Respiratory Insuffici... More >>ency|Telmisartan|Respiratory Distress Syndrome, Adult Less << PHASE2 COMPLETED 2021-05-25 Hospital Regional de Alta Espe... More >>cialidad de Zumpango, Zumpango, Estado De Mexico, 55600, Mexico Less <<
NCT00879411 Hypertension COMPLETED - -
NCT02187484 Hypertension PHASE2 COMPLETED - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.72mL

1.94mL

0.97mL

19.43mL

3.89mL

1.94mL

References

 

Historical Records

Categories